No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 116,375 | 111,829 | 131,054 | 146,194 | 165,541 | 188,677 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 2,026 | 1,638 | 1,769 | 2,019 | 2,358 | 2,544 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
GSI Creos Corporation, headquartered in Tokyo, Japan, operates globally, providing an extensive array of textiles and industrial products. The company furnishes natural and synthetic fibers, serving as components for materials used in innerwear, hosiery, sweaters, and bedding. It also supplies fabrics to apparel manufacturers, as well as for furniture and various other goods. Its clothing lines encompass men's, women's (marketed under brands like Mashu Kashu, FRICOT PLUS, NONA, and STAY YOU), and children's apparel, alongside outdoor wear and sportswear. Beyond textiles, the firm extends its reach into diverse consumer products. These include modeling paints, tools, and plastic models sold under the Mr. HOBBY brand. It offers toothbrushes, notably the HAIKARA: full brand, and facial masks branded ChamU. Further consumer goods comprise loungewear, towels, neck pillows, gloves, and bras, including those from the LaLa Glange brand. In the health and medical sector, GSI Creos provides non-woven and specialized cloth masks. It also supplies consumables and related equipment for dialysis machines, along with the machines themselves. The company is a source for natural colorant butterfly pea extract powder and pinitol, an ingredient known for blood sugar level regulation. Its comprehensive industrial portfolio features cosmetic raw materials; nail art accessories such as brushes, oils, files, and toenail stockings, in addition to cleaners and washers under the CON'CELECT brand. The company is involved with high-performance particle coating devices, vaporizers for film deposition, wafer transfer robots, deformation measuring instruments, and silicon wafers. Other advanced materials and machinery supplied include carbon nanotubes, plastic molding equipment, textile machinery, electrical discharge machines, ion exchange resins, filters, fluorine tubes and materials, self-healing paints, glass parting agents, high-performance papers, materials for manufacturing high-pressure rubber hoses, and cleaning agents. Furthermore, it deals in crosslinking agents, functional additives, anti-rust agents, coating resins, plastic resins, and various packaging, industrial, and functional films. Customers can also acquire these items directly through the company's e-commerce platform. Incorporated in 1931, the company was originally known as Gunze Sangyo, Inc., before changing its name to GSI Creos Corporation in 2001.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
GSI Creos Corporation, headquartered in Tokyo, Japan, operates globally, providing an extensive array of textiles and industrial products. The company furnishes natural and synthetic fibers, serving as components for materials used in innerwear, hosiery, sweaters, and bedding. It also supplies fabrics to apparel manufacturers, as well as for furniture and various other goods. Its clothing lines encompass men's, women's (marketed under brands like Mashu Kashu, FRICOT PLUS, NONA, and STAY YOU), and children's apparel, alongside outdoor wear and sportswear. Beyond textiles, the firm extends its reach into diverse consumer products. These include modeling paints, tools, and plastic models sold under the Mr. HOBBY brand. It offers toothbrushes, notably the HAIKARA: full brand, and facial masks branded ChamU. Further consumer goods comprise loungewear, towels, neck pillows, gloves, and bras, including those from the LaLa Glange brand. In the health and medical sector, GSI Creos provides non-woven and specialized cloth masks. It also supplies consumables and related equipment for dialysis machines, along with the machines themselves. The company is a source for natural colorant butterfly pea extract powder and pinitol, an ingredient known for blood sugar level regulation. Its comprehensive industrial portfolio features cosmetic raw materials; nail art accessories such as brushes, oils, files, and toenail stockings, in addition to cleaners and washers under the CON'CELECT brand. The company is involved with high-performance particle coating devices, vaporizers for film deposition, wafer transfer robots, deformation measuring instruments, and silicon wafers. Other advanced materials and machinery supplied include carbon nanotubes, plastic molding equipment, textile machinery, electrical discharge machines, ion exchange resins, filters, fluorine tubes and materials, self-healing paints, glass parting agents, high-performance papers, materials for manufacturing high-pressure rubber hoses, and cleaning agents. Furthermore, it deals in crosslinking agents, functional additives, anti-rust agents, coating resins, plastic resins, and various packaging, industrial, and functional films. Customers can also acquire these items directly through the company's e-commerce platform. Incorporated in 1931, the company was originally known as Gunze Sangyo, Inc., before changing its name to GSI Creos Corporation in 2001.
